The Social Security (Industrial Injuries) (Prescribed Diseases) Amendment Regulations 2005

• Citation: S.I. 2005/324
• Sections: 4

Section 1 Citation, commencement and interpretation

(1) These Regulations may be cited as the Social Security (Industrial Injuries) (Prescribed Diseases) Amendment Regulations 2005 and shall come into force on 14th March 2005.

(2) In these Regulations “the principal Regulations ” means the Social Security (Industrial Injuries) (Prescribed Diseases) Regulations 1985 .

Section 2 Amendment of regulations 2 and 25 of the principal Regulations

(1) In regulation 2(c) of the principal Regulations (occupational deafness) the words after “to these regulations” shall be omitted.

(2) In regulation 25(2) of the principal Regulations (time for claiming for occupational deafness) the words after “prescribed in relation to occupational deafness” shall be omitted.

Section 3 Amendment of Schedule 1 to the principal Regulations

(1) Part I of Schedule 1 to the principal Regulations (list of prescribed diseases and the occupations for which they are prescribed) shall be amended as follows.

(2) After the entry relating to prescribed disease A12 there shall be added the following entry—

(A13) Osteoarthritis of the hip.

(3) For the entry relating to prescribed disease B1 there shall be substituted—

(B1) Anthrax.

(a) Contact with anthrax spores, including contact with animals infected by anthrax; or

(b) handling, loading, unloading or transport of animals of a type susceptible to infection with anthrax or of the products or residues of such animals.

(4) For the entry relating to prescribed disease B4 there shall be substituted—

(B4) Ankylostomiasis.

(5) For the entry relating to prescribed disease B8 there shall be substituted—

(B8A) Infection by hepatitis A virus.

(B8B) Infection by hepatitis B or C virus.

Contact with—

human blood or human blood products; or

any other source of hepatitis B or C virus.

(6) After the entry relating to prescribed disease B13 there shall be added the following entries—

(B14) Lyme disease.

(B15) Anaphylaxis.

(7) In the first column of the entry relating to prescribed disease D4 (allergic rhinitis), after sub-paragraph (w) there shall be added—

(x) products made with natural rubber latex.

(8) In the first column of the entry relating to prescribed disease D7 (asthma), after sub-paragraph (w) there shall be inserted—

(wa) products made with natural rubber latex;

Section 4 Transitional provision

Regulation 3 shall not apply to a period of assessment which relates to a claim which is made before the date on which these Regulations come into force.